PAPER Dinter E, Saridaki T, Diederichs L, Reichmann H, Falkenburger BH
SEARCH RESULTS
270366 RESULTS
PAPER Yuan TF, Li WG, Zhang C, Wei H, Sun S, Xu NJ, Liu J, Xu TL
Targeting neuroplasticity in patients with neurodegenerative diseases using brain stimulation techniques.
Transl Neurodegener. 2020 Dec 7;9(1):44. PubMed.PAPER Naini SM, Yanicostas C, Hassan-Abdi R, Blondeel S, Bennis M, Weiss RJ, Tor Y, Esko JD, Soussi-Yanicostas N
Correction to: Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathy.
Transl Neurodegener. 2020 Dec 20;9(1):45. PubMed.PAPER Ng KP, Pascoal TA, Mathotaarachchi S, Chan YH, Jiang L, Therriault J, Benedet AL, Shin M, Kandiah N, Greenwood CM, Rosa-Neto P, Gauthier S, Dominantly Inherited Alzheimer Network
Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease.
Transl Neurodegener. 2021 Jan 4;10(1):1. PubMed.PAPER Shinomoto M, Kasai T, Tatebe H, Kitani-Morii F, Ohmichi T, Fujino Y, Allsop D, Mizuno T, Tokuda T
Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer's disease.
Transl Neurodegener. 2021 Jan 4;10(1):2. PubMed.PAPER Cheng Y, Chen Y, Shang H
Aberrations of biochemical indicators in amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Transl Neurodegener. 2021 Jan 8;10(1):3. PubMed.PAPER Behl T, Kaur G, Fratila O, Buhas C, Judea-Pusta CT, Negrut N, Bustea C, Bungau S
Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review.
Transl Neurodegener. 2021 Jan 15;10(1):4. PubMed.PAPER Kamienieva I, Duszyński J, Szczepanowska J
Multitasking guardian of mitochondrial quality: Parkin function and Parkinson's disease.
Transl Neurodegener. 2021 Jan 20;10(1):5. PubMed.PAPER Zhang Y, Wang Y, Shi C, Shen M, Lu F
Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer's disease.
Transl Neurodegener. 2021 Feb 1;10(1):6. PubMed.PAPER Morató X, Garcia-Esparcia P, Argerich J, Llorens F, Zerr I, Paslawski W, Borràs E, Sabidó E, Petäjä-Repo UE, Fernández-Dueñas V, Ferrer I, Svenningsson P, Ciruela F
Ecto-GPR37: a potential biomarker for Parkinson's disease.
Transl Neurodegener. 2021 Feb 26;10(1):8. PubMed.PAPER Huang X, Wong G
An old weapon with a new function: PIWI-interacting RNAs in neurodegenerative diseases.
Transl Neurodegener. 2021 Mar 8;10(1):9. PubMed.PAPER Ding X, Zhang S, Jiang L, Wang L, Li T, Lei P
Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer's disease: a systematic review and meta-analysis.
Transl Neurodegener. 2021 Mar 12;10(1):10. PubMed.PAPER Ng KP, Chiew H, Rosa-Neto P, Kandiah N, Ismail Z, Gauthier S
Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer's disease and cognitively unimpaired individuals.
Transl Neurodegener. 2021 Mar 31;10(1):11. PubMed.PAPER Wang J, Hu HJ, Liu ZK, Liu JJ, Wang SS, Cheng Q, Chen HZ, Song M
Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer's disease-related pathologies in a senescence-accelerated mouse model.
Transl Neurodegener. 2021 Mar 31;10(1):12. PubMed.PAPER Xia X, Wang Y, Zheng J
COVID-19 and Alzheimer's disease: how one crisis worsens the other.
Transl Neurodegener. 2021 Apr 30;10(1):15. PubMed.Current Filters
- TYPE: Paper x